Real-life stories from survivors of cancer and other diseases who have used the 9 key factors from the New York Times best-selling Radical Remission, with updated research and a tenth key factor revealed.
Following the publication of the New York Times best-selling Radical Remission, researcher Kelly A. Turner, Ph.D., has collected hundreds of new cases of radical remissions—from cancer and now also other diseases—from across the globe. In Radical Hope, Turner explores the real-life application of the Radical Remission principles and the people who have chosen to take this journey.
Each chapter shares a survivor’s in-depth story and their use of one of the ten key Radical Remission healing factors. Turner provides updated scientific research and new tips for each factor, and unveils a tenth key factor for integration into your healing approach. Male and female, young and old, these survivors recognize that by taking ownership of their approach to healing, they are giving themselves the best chance for a longer and healthier life, with the ultimate goal of achieving remission.
With warmth, realness, and a true sense of hope, Turner shines the spotlight on the pure strength of the human spirit and offers steadfast support and guidance for making the unique and individual decisions that lead to a powerful journey of healing.
GET IT FREE HERE
This comprehensive and established textbook presents an up-to-date overview of all aspects of managing children with cancer and in its third edition has been completely revised and updated to reflect recent developments in the field. Individual malignancies are given comprehensive coverage, including details of clinical presentation, diagnostic investigations, novel imaging techniques and current management with chemotherapy, radiotherapy and surgery.
Current controversies relating to diagnosis and management – a popular feature of previous editions – are presented in boxes for increased emphasis. Content changes to the new edition include a restructured pathology section and new chapters under separate headings of ‘advances in therapy’ and ‘late effects and supportive care’.
Retaining a European flavour, but incorporating information from American and other national studies to give an objective and comprehensive overview, the third edition of Paediatric Oncology remains invaluable reading for trainee and practising paediatric oncologists, and nurse specialists, world-wide.
[contributors mainly UK and European, plus 1 from US and 1 from Australia]
GET IT FREE HERE
This handbook is a concise, thorough, and portable reference guide to the multitude of complex chemotherapy protocols and other frequently utilized medications in the field of Hematology/Oncology. Its inclusion of commonly used oncology regimens, guidelines for supportive care during administration and sections on pain control, antibiotic use and antiemesis guidelines set it apart from other ?chemotherapy handbooks?. The authors have prepared this book with the intention of improving the care of those suffering from cancer.
GET IT FREE HERE
For thousands of years, physicians observed cases of “spontaneous remissions” from cancer. These sudden and dramatic cancer cures were chalked up to magic or miracle. In fact it was the immune system, mysteriously unleashed.
Now scientists have learned to recreate that miracle with medicines so new that cancer patients- and even many doctors- don’t realize they exist.
From the New York Times bestselling author of The Good Nurse comes an empowering and accessible story of the discoveries of the tricks cancer uses to avoid the immune system, and the important new cancer immunotherapies already unleashing the immune system to fight – and beat – the disease.
Four years in the writing, THE BREAKTHROUGH is an “exciting read” about the discoveries which received the 2018 Nobel Prize winning discoveries in October, and a dramatic and exciting turning point in our relationship with a disease that has for too long defined us.
For decades, scientists have puzzled over one of medicine’s most confounding mysteries: Why doesn’t our immune system recognize and fight cancer the way it does other diseases, like the common cold?
As it turns out, the answer to that question can be traced to a series of tricks that cancer has developed to turn off normal immune responses-tricks that scientists have only recently discovered and learned to defeat. The result is what many are calling cancer’s “penicillin moment,” a revolutionary discovery in our understanding of cancer and how to beat it.
In THE BREAKTHROUGH, Graeber guides us through the surprisingly recent scientific discoveries that change the way we will treat- and maybe even beat- cancer in the years to come.
Amazingly, many patients, and even many doctors, are not fully aware of what many are calling our “penicillin moment” with cancer. With literally thousands of new therapies that harness the power of the immune system to recognize and fight cancer in clinical trials, it’s never been more important for patients to understand their choices, and empowered to ask better questions. In the new war against cancer, information is now a crucial weapon.
Groundbreaking, riveting, and expertly told, THE BREAKTHROUGH is a scientific mystery story about the quest to unleash our natural ability to recognize and defeat cancer, told through the experiences of the patients, physicians, and cancer immunotherapy researchers who are on the front lines. This is the incredible true story of the race to find a cure, a dispatch from the life-changing world of modern oncological science, and a brave new chapter in medical history.
GET IT FREE HERE
“..it is increasingly clear that cancer is also a disease of inertia. In this book, a broadly multidisciplinary group presents the evidence and provides the recommendations. … The antidote to diseases of inertia is movement — let’s move!” John Potter, M.D.,Ph.D., from the Foreword The American Cancer Society estimates that a third of all cancer deaths could be prevented through avoidance of obesity and the rejection of sedentary lifestyles. The World Health Organization also supports this claim. Additionally, these and other organizations now recognize the role that activity can play in improving the quality of life for cancer patients. Cancer Prevention and Management through Exercise and Weight Control provides us with the support necessary to make a call to action. Itbrings together the contributions of world-class researchers to lay out the evidence and a plan of attack for coping with this crisis. The text begins by focusing on the research methods used in assessing the complex associations between activity, energy balance, and risk and prognosis. In comprehensive literature reviews, the authors consider the role of physical activity in the incidence of individual cancers, then explore the mechanisms that might explain this connection. They continue with a look at the relation between weight and cancer incidence, including a consideration of genetics. Research is also provided linking physical activity and weight control to a cancer patient’s quality of life and prognosis. The work concludes with ideas on how a plan of action might be implemented at the individual, clinical, and public health levels. It also provides guidance on incorporating exercise and diet recommendations into clinical oncology practice.
GET IT FREE HERE
This book is a state-of-the-art overview of cancer regional therapy (CRT) for the surgeons and interventional radiologists active in CRT development and research. The goals of this book are 1) to review the theory and practice of cancer regional therapies including pharmacology, devices, techniques, and workflow, 2) illustrate the most common procedures performed in the interventional and operating rooms, and 3) discuss data supporting use of CRT. This is meant to be a definitive text on the theory and practice of CRT. It begins with a summary of the history, technical principles that underlie regional therapy. The following parts discuss current data and practice in peritoneal, liver, limb, pleural and other sites. Included in the practice are considerations of workflow and financial issues revolving around CRT. Novel techniques and therapies under investigation are presented to inform the direction of the field.
Cancer Regional Therapy summarizes the history, current technology, common procedures, and future prospects in this field and includes procedures from many surgical and interventional radiologic disciplines.
GET IT FREE HERE
When we think of the forces driving cancer, we don’t necessarily think of evolution. But evolution and cancer are closely linked, for the historical processes that created life also created cancer. The Cheating Cell delves into this extraordinary relationship, and shows that by understanding cancer’s evolutionary origins, researchers can come up with more effective, revolutionary treatments.
Athena Aktipis goes back billions of years to explore when unicellular forms became multicellular organisms. Within these bodies of cooperating cells, cheating ones arose, overusing resources and replicating out of control, giving rise to cancer. Aktipis illustrates how evolution has paved the way for cancer’s ubiquity, and why it will exist as long as multicellular life does. Even so, she argues, this doesn’t mean we should give up on treating cancer—in fact evolutionary approaches offer new and promising options for the disease’s prevention and treatments that aim at long-term management rather than simple eradication. Looking across species—from sponges and cacti to dogs and elephants—we are discovering new mechanisms of tumor suppression and the many ways that multicellular life-forms have evolved to keep cancer under control. By accepting that cancer is a part of our biological past, present, and future—and that we cannot win a war against evolution—treatments can become smarter, more strategic, and more humane.
Unifying the latest research from biology, ecology, medicine, and social science, The Cheating Cell challenges us to rethink cancer’s fundamental nature and our relationship to it.
GET IT FREE HERE
Management of tumor patients now relies on new individualized approaches to treatment, requiring extensive knowledge of the molecular makeup of tumors. Updated and expanded, the third edition of Atlas of Differential Diagnosis in Neoplastic Hematopathology examines not only the differential diagnosis but also the detailed morphologic, immunophenotypic, and especially genetic characteristics of the majority of hematolymphoid malignancies.
Featuring a new structure and including new chapters, the third edition updates all content and presents considerable expansion on many topics, including:
– Metaphase cytogenetic and FISH
– Flow cytometry (overview and detailed analysis of specific tumors)
– Acute myeloid leukemia and new classification schemes
– MDS, AML, and B- and T-cell lymphoproliferations
– Abnormal patterns in the lymph node and bone marrow with detail differential diagnosis based on histologic features and cellular composition
– Detailed differential diagnosis based on the expression of broad list of antigenic markers (flow cytometry and immunohistochemistry)
– Extranodal lymphomas
– Diagnosis of MDS and myeloproliferative neoplasm and their differential diagnosis based on the morphologic, flow cytometric, and chromosomal features
The book also provides expanded differential diagnosis of the most common as well as most difficult and rare entities, including morphologic, immunophenotypic, and karyotypic/molecular features. This edition includes updated algorithms for most common diagnoses as well as several new algorithms. The majority of figures have been revised and are in full color.
GET IT FREE HERE